about
A single amino acid determines preference between phospholipids and reveals length restriction for activation of the S1P4 receptorMechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymesLysophospholipids and their receptors in the central nervous systemFingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapyBehavioral phenotype of maLPA1-null mice: increased anxiety-like behavior and spatial memory deficitsLipid phosphate phosphatases regulate lysophosphatidic acid production and signaling in platelets: studies using chemical inhibitors of lipid phosphate phosphatase activityTandem genomic arrangement of a G protein (Gna15) and G protein-coupled receptor (s1p(4)/lp(C1)/Edg6) geneThe Sphingosine-1-phospate receptor 1 mediates S1P action during cardiac developmentReceptor-mediated vascular smooth muscle migration induced by LPA involves p38 mitogen-activated protein kinase pathway activationLPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activationSelective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3Selective blockade of lysophosphatidic acid LPA3 receptors reduces murine renal ischemia-reperfusion injury.International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.Biological roles of lysophospholipid receptors revealed by genetic null mice: an update.Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis.LPA receptor signaling: pharmacology, physiology, and pathophysiology.Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis.Dual regulation of actin rearrangement through lysophosphatidic acid receptor in neuroblast cell lines: actin depolymerization by Ca(2+)-alpha-actinin and polymerization by rhoLysophospholipid receptor nomenclature review: IUPHAR Review 8.Aggravation of chronic stress effects on hippocampal neurogenesis and spatial memory in LPA₁ receptor knockout mice.Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2).Lysophosphatidic acid acts as a nutrient-derived developmental cue to regulate early hematopoiesis.Functional disassociation of the central and peripheral fatty acid amide signaling systems.Cell density-dependent expression of EDG family receptors and mesangial cell proliferation: role in lysophosphatidic acid-mediated cell growth.The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine.Involvement of lysophosphatidic acid in bone cancer pain by potentiation of TRPV1 via PKCε pathway in dorsal root ganglion neurons.Regulating survival and development in the retina: key roles for simple sphingolipids.Identification of X-linked genes required for migration and programmed cell death of Drosophila melanogaster germ cellsNeurobiology of lysophosphatidic acid signaling.Lysophosphatidic acid in vascular development and diseaseT cell chemotaxis to lysophosphatidylcholine through the G2A receptor.Mitigation of the hematopoietic and gastrointestinal acute radiation syndrome by octadecenyl thiophosphate, a small molecule mimic of lysophosphatidic acidAnatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain.Lysophosphatidic acid signaling protects pulmonary vasculature from hypoxia-induced remodeling.Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling.Lysophosphatidic acid stimulates astrocyte proliferation through LPA1Rapid induction of medullary thymocyte phenotypic maturation and egress inhibition by nanomolar sphingosine 1-phosphate receptor agonistHDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.Metabolite and Lipid Profiling of Biobank Plasma Samples Collected Prior to Onset of Rheumatoid Arthritis.
P2860
Q21093656-D47F8BC3-5845-4B9B-B2FB-7AEFE4C2DEACQ24680869-DE73CD6E-0AAB-4306-9A5F-7385064AD8B3Q26859168-6D490105-B351-46D5-AF2A-03EAB3C629D0Q27011473-78DBEEB2-473C-4638-9BBF-D15D9C76EE28Q27349027-262E5BF8-E7D9-4B41-8AC1-C66E87DCB37EQ28156404-C395A555-205E-47D7-80EE-70C36A3A7F2CQ28210981-FBE5E34B-9618-4736-8323-D2628E0FBF17Q28512659-C55F90E1-9243-400C-A1BC-1C8F4B0B14CEQ28582283-F795D8A3-2686-439C-AF5F-300025158192Q28589775-20B5BFDD-200B-4E5B-ADDD-C5C73492908CQ28593745-A52758B3-5D45-405B-9426-8CF59CCCC83CQ30310878-8831DF17-ECBD-4529-899B-E924C676E8BFQ30429523-F90B37FC-6820-4F91-9A1D-7FCCC930B906Q30487082-7C37F1BC-900B-4B5D-ACD6-DFB3C1598530Q33753311-CA028381-E10C-4290-B78D-FE95AAC6F4B8Q33810559-58EBC25A-0285-4F70-955C-FFD86D4BB5E3Q33825153-97B9A89D-1DF1-4025-A8C2-482B72DC8002Q33881977-F777CBDA-6EBE-4204-9351-8D43364559DDQ33902903-3A7E33A0-C39C-4EDE-AAD6-0754E3DC6A6AQ34025135-388F8067-F689-406D-80A5-1C6C0AE59DBCQ34043311-CD750F7A-386E-4F21-A069-419F496F320CQ34285790-4040F77E-AF82-4E39-AF25-AEAFF0FCBAD7Q34324614-BA8CD501-7798-426F-885E-8CD8D4583236Q34332678-2B7A27ED-C008-4F1E-A60A-B2CE58CEAFE4Q34338371-6F67AB17-3FBE-4DD9-9A2D-05B2E2393A0EQ34357465-CAE2CF15-1327-4344-AE23-A22857A3B92EQ34419164-AB188723-A7DC-410F-96B1-750FFB2E1C92Q34559806-1F32501A-07C7-48F2-8577-2AADA191C9B1Q34616011-12C7AD3A-BC6E-44C1-A7F5-9757AA1FBB3DQ35017623-BE47350C-D27E-4D49-9938-BC4C5BE8BFFAQ35018207-3AB6DF6D-F003-40DA-A9DE-84255F7D961AQ35122285-B6AA9570-5E9D-418E-9DBA-50960AE0856DQ35597324-709E8294-348C-46A4-9E48-2E316FF19DC8Q35598539-8065427C-D8EB-4FA3-8C65-5C6DC5CD0D4FQ35621592-F9D5A3FC-79FF-403B-8A73-50F05D5CAA77Q35684044-96D65A06-02EF-4536-8383-B4ACF901CA70Q35694255-6DA020AE-3E57-44C1-B4BF-631CCD8E667BQ35978652-471E3D03-F296-43F0-9AFC-98C1AE1092E7Q36056673-BC786EC5-E6FD-45CD-9C0C-41310F3B5676Q36166090-43BABC17-0E29-462A-9281-77ACD88077BD
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Lysophospholipid receptors.
@ast
Lysophospholipid receptors.
@en
Lysophospholipid receptors.
@nl
type
label
Lysophospholipid receptors.
@ast
Lysophospholipid receptors.
@en
Lysophospholipid receptors.
@nl
prefLabel
Lysophospholipid receptors.
@ast
Lysophospholipid receptors.
@en
Lysophospholipid receptors.
@nl
P2093
P1476
Lysophospholipid receptors.
@en
P2093
P304
P356
10.1146/ANNUREV.PHARMTOX.41.1.507
P577
2001-01-01T00:00:00Z